Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
Background & Aims Multiparametric magnetic resonance (MR) imaging has been demonstrated to quantify hepatic fibrosis, iron, and steatosis. The aim of this study was to determine if MR can be used to predict negative clinical outcomes in liver disease patients. Methods Patients with chronic l...
| Váldodahkkit: | , , , , , , , , |
|---|---|
| Materiálatiipa: | Journal article |
| Giella: | English |
| Almmustuhtton: |
Elsevier
2015
|
| _version_ | 1826289184039501824 |
|---|---|
| author | Pavlides, M Banerjee, R Sellwood, J Kelly, C Robson, M Booth, J Collier, J Neubauer, S Barnes, E |
| author_facet | Pavlides, M Banerjee, R Sellwood, J Kelly, C Robson, M Booth, J Collier, J Neubauer, S Barnes, E |
| author_sort | Pavlides, M |
| collection | OXFORD |
| description | Background & Aims Multiparametric magnetic resonance (MR) imaging has been demonstrated to quantify hepatic fibrosis, iron, and steatosis. The aim of this study was to determine if MR can be used to predict negative clinical outcomes in liver disease patients. Methods Patients with chronic liver disease (n = 112) were recruited for MR imaging and data on the development of liver related clinical events were collected by medical records review. The median follow-up was 27 months. MR data were analysed blinded for the Liver Inflammation and Fibrosis score (LIF; <1, 1–1.99, 2–2.99, and ⩾3 representing normal, mild, moderate, and severe liver disease, respectively), T2∗ for liver iron content and proportion of liver fat. Baseline liver biopsy was performed in 102 patients. Results Liver disease aetiologies included non-alcoholic fatty liver disease (35%) and chronic viral hepatitis (30%). Histologically, fibrosis was mild in 54 (48%), moderate in 17 (15%), and severe in 31 (28%) patients. Overall mortality was 5%. Ten patients (11%) developed at least one liver related clinical event. The negative predictive value of LIF <2 was 100%. Two patients with LIF 2–2.99 and eight with LIF ⩾3 had a clinical event. Patients with LIF ⩾3 had a higher cumulative risk for developing clinical events, compared to those with LIF <1 (p = 0.02) and LIF 1–1.99 (p = 0.03). Cox regression analysis including all 3 variables (fat, iron, LIF) resulted in an enhanced LIF predictive value. Conclusions Non-invasive standardised multiparametric MR technology may be used to predict clinical outcomes in patients with chronic liver disease. |
| first_indexed | 2024-03-07T02:25:01Z |
| format | Journal article |
| id | oxford-uuid:a54c1cad-1db0-412c-b1d9-42c518d9e5ad |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T02:25:01Z |
| publishDate | 2015 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:a54c1cad-1db0-412c-b1d9-42c518d9e5ad2022-03-27T02:39:31ZMultiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a54c1cad-1db0-412c-b1d9-42c518d9e5adEnglishSymplectic Elements at OxfordElsevier2015Pavlides, MBanerjee, RSellwood, JKelly, CRobson, MBooth, JCollier, JNeubauer, SBarnes, EBackground & Aims Multiparametric magnetic resonance (MR) imaging has been demonstrated to quantify hepatic fibrosis, iron, and steatosis. The aim of this study was to determine if MR can be used to predict negative clinical outcomes in liver disease patients. Methods Patients with chronic liver disease (n = 112) were recruited for MR imaging and data on the development of liver related clinical events were collected by medical records review. The median follow-up was 27 months. MR data were analysed blinded for the Liver Inflammation and Fibrosis score (LIF; <1, 1–1.99, 2–2.99, and ⩾3 representing normal, mild, moderate, and severe liver disease, respectively), T2∗ for liver iron content and proportion of liver fat. Baseline liver biopsy was performed in 102 patients. Results Liver disease aetiologies included non-alcoholic fatty liver disease (35%) and chronic viral hepatitis (30%). Histologically, fibrosis was mild in 54 (48%), moderate in 17 (15%), and severe in 31 (28%) patients. Overall mortality was 5%. Ten patients (11%) developed at least one liver related clinical event. The negative predictive value of LIF <2 was 100%. Two patients with LIF 2–2.99 and eight with LIF ⩾3 had a clinical event. Patients with LIF ⩾3 had a higher cumulative risk for developing clinical events, compared to those with LIF <1 (p = 0.02) and LIF 1–1.99 (p = 0.03). Cox regression analysis including all 3 variables (fat, iron, LIF) resulted in an enhanced LIF predictive value. Conclusions Non-invasive standardised multiparametric MR technology may be used to predict clinical outcomes in patients with chronic liver disease. |
| spellingShingle | Pavlides, M Banerjee, R Sellwood, J Kelly, C Robson, M Booth, J Collier, J Neubauer, S Barnes, E Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease |
| title | Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease |
| title_full | Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease |
| title_fullStr | Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease |
| title_full_unstemmed | Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease |
| title_short | Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease |
| title_sort | multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease |
| work_keys_str_mv | AT pavlidesm multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease AT banerjeer multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease AT sellwoodj multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease AT kellyc multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease AT robsonm multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease AT boothj multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease AT collierj multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease AT neubauers multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease AT barnese multiparametricmagneticresonanceimagingpredictsclinicaloutcomesinpatientswithchronicliverdisease |